In vitro and in vivo anti-Pseudomonas aeruginosa activity of a scorpion peptide derivative
HTP2 could effectively kill <i>P. aeruginosa in vitro</i> and <i>in vivo</i>, and had the potential as an anti-<i>P. aeruginosa</i> agent.
Authors
- Yanfang Dong (ORCID: https://orcid.org/0000-0001-9834-7157)
- Wanwu Li (ORCID: https://orcid.org/0000-0002-7960-3554)
- Bo Deng (ORCID: https://orcid.org/0000-0003-0889-7257)
- Pengfei Wu (ORCID: https://orcid.org/0000-0001-7621-5970)
- Pengyang Xin (ORCID: https://orcid.org/0000-0003-4947-7953)
- Jiao Zhang (ORCID: https://orcid.org/0000-0002-2881-7755)
- Shasha Li (ORCID: https://orcid.org/0000-0002-7383-866X)
- Zhongjie Li (ORCID: https://orcid.org/0000-0002-2753-9212)
- Wenlu Zhang (ORCID: https://orcid.org/0000-0003-1973-6037)
- Yabo Liu (ORCID: https://orcid.org/0000-0001-7535-9366)
- Dai Qi
Institutions
- Henan University of Science and Technology (CN)
- National Medical Products Administration (CN)
- Henan Normal University (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.3389/fmicb.2025.1622282
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China